News
Winnie Byanyima says her organization has lost almost 50% of its funding, a gap that is undermining global efforts to combat ...
FDA Approves Yeztugo as First Twice-Yearly Injectable HIV Prevention Option in the U.S. Clinical Trials Show Near-Perfect ...
Amy Grant joined artists Matt Maher, Brandon Health, Charlie Peacock and Steve Taylor at a performance at Otter Creek Church ...
16h
Discover Magazine on MSNFDA Approves Breakthrough HIV Drug, but It Could Be Hard to AccessLearn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback.
21h
Baller Alert on MSNTwice-a-Year HIV Prevention Shot Approved in U.S.—No More Daily PillsThe U.S. has just approved a powerful new weapon in the fight against HIV: a twice-a-year prevention shot called Yeztugo. Made by Gilead Sciences, the injectable treatment slashes the risk […] The ...
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
In two recent studies, this new shot reportedly nearly eliminated new infections in people at substantial risk of HIV.
Dozens of HIV experts at the Centers for Disease Control and Prevention received emails earlier in June revoking notices they ...
Kathy Seward MacKay lost her husband in 1997 because of tainted blood-clotting products. She’s worried about history ...
1d
India Today on MSNLenacapavir becomes first FDA-approved HIV preventive drug: All about itThe US FDA has approved lenacapvir, sold under the brand name Yeztugo, as the first preventive treatment against HIV. It is a ...
WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results